56 related articles for article (PubMed ID: 10883668)
1. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).
Mirza KA; Wyke SM; Tisdale MJ
Br J Cancer; 2011 Jun; 105(1):83-8. PubMed ID: 21673682
[TBL] [Abstract][Full Text] [Related]
2. Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma.
Okamura A; Ohmura Y; Islam MM; Tagawa M; Horitsu K; Moriyama Y; Fujimura S
Jpn J Cancer Res; 1998 Jun; 89(6):649-56. PubMed ID: 9703363
[TBL] [Abstract][Full Text] [Related]
3. Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.
Naoe Y; Kawamura I; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
Jpn J Cancer Res; 1998 Dec; 89(12):1318-25. PubMed ID: 10081493
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy before tumor inoculation prolongs the survival time of cachectic mice.
Soda K; Kawakami M; Takagi S; Kashii A; Miyata M
Cancer Immunol Immunother; 1995 Oct; 41(4):203-9. PubMed ID: 7489562
[TBL] [Abstract][Full Text] [Related]
5. The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Br J Cancer; 2010 Mar; 102(5):833-6. PubMed ID: 20145616
[TBL] [Abstract][Full Text] [Related]
6. Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice.
Iseki H; Kajimura N; Ohue C; Tanaka R; Akiyama Y; Yamaguchi K
Jpn J Cancer Res; 1995 Jun; 86(6):562-7. PubMed ID: 7622421
[TBL] [Abstract][Full Text] [Related]
7. Presence of normal human cell surface antigens in plasma of athymic mice bearing a human colon carcinoma and in normal human plasma.
Markson Y; Weiss DW; Weiss O; Doljanski F
Cancer Immunol Immunother; 1985; 20(2):129-36. PubMed ID: 3849977
[TBL] [Abstract][Full Text] [Related]
8. Resistance Training Attenuates Activation of STAT3 and Muscle Atrophy in Tumor-Bearing Mice.
Testa MTJ; Cella PS; Marinello PC; Frajacomo FTT; Padilha CS; Perandini PC; Moura FA; Duarte JA; Cecchini R; Guarnier FA; Deminice R
Front Oncol; 2022; 12():880787. PubMed ID: 35847939
[TBL] [Abstract][Full Text] [Related]
9. The multiple facets of dermcidin in cell survival and host defense.
Schittek B
J Innate Immun; 2012; 4(4):349-60. PubMed ID: 22455996
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
Smith HJ; Tisdale MJ
Br J Cancer; 2003 Nov; 89(9):1783-8. PubMed ID: 14583784
[TBL] [Abstract][Full Text] [Related]
11. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
12. Loss of skeletal muscle in cancer: biochemical mechanisms.
Tisdale MJ
Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
[TBL] [Abstract][Full Text] [Related]
13. Effects of eicosapentaenoic acid on tumour growth and cachexia in mouse colon cancer.
Tisdale MJ; Beck SA; Hudson EA
World Rev Nutr Diet; 1994; 76():86-8. PubMed ID: 7856243
[No Abstract] [Full Text] [Related]
14. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
[TBL] [Abstract][Full Text] [Related]
15. 5'-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice.
Eda H; Tanaka Y; Ishitsuka H
Cancer Chemother Pharmacol; 1991; 29(1):1-6. PubMed ID: 1835906
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
